(EMAILWIRE.COM, July 26, 2019 ) According to the new market research report "Protein Expression Market by Type (E. Coli, Mammalian, Yeast, Pichia, Insect, Baculovirus, Cell-free), Products (Competent Cells, Reagents, Instruments, Services), Application (Therapeutic, Research, Industrial) & End User - Global Forecast to 2022 ", published by MarketsandMarkets™.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180323924

The prevalence of chronic diseases, increasing research activities on recombinant-based proteins, and growing life sciences & biopharmaceutical industries are the major factors driving the growth of this market.

Browse and in-depth TOC on "Protein Expression Market"
127 - Tables
38 - Figures
173 - Pages

By end user, the pharmaceutical and biotechnology companies segment is expected to hold the largest share of the market in 2017

On the basis of end users, the protein expression market is segmented into academic research institutes; contract research organizations (CROs); pharmaceutical and biotechnology companies; and other end users (food processing industry, detergent manufacturers, paper industry, leather industry, breweries, dairy industry, chemical industry, bioplastic industry, and cosmeceutical industry).

Asia offers lucrative growth opportunities

By region, the global protein expression market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). While North America holds the largest share of the market in 2016, Asia is expected to grow at the highest CAGR during the forecast period. The presence of emerging economies like China and India; the large population and rising prevalence of chronic diseases in these countries; a growing demand of biologics; and the improving life sciences research infrastructure are the major factors driving the growth of this regional segment.

Read More in Detailed: https://www.marketsandmarkets.com/PressReleases/protein-expression.asp

Key players operating in the protein expression market include Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson & Company (U.S.), Agilent Technologies, Inc. (U.S.), QIAGEN N.V. (Netherlands), Takara Bio Inc. (Japan), Lonza Group Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), GenScript Biotech Corporation (China), Lucigen Corporation (U.S.), Synthetic Genomics Inc. (U.S.), Promega Corporation (U.S.)